Frost & Sullivan selected Quintiles based on its in-depth evaluation of CRO companies&39.

Frost & Sullivan selected Quintiles based on its in-depth evaluation of CRO companies' performance in the current Asia Pacific market landscape and its own emerging trends. ‘Quintiles may be the clear market head in the Asia Pacific CRO scenery,’ said Rhenu Bhuller, Partner and Senior Vice President, Health care, Frost & Sullivan. Quintiles obtained in every criteria highly, and particularly so in 'pioneering best practices' and 'addressing unmet needs'.’ ‘For instance, Quintiles launched a devoted medical devices unit in Asia Pacific in 2015 that leverages the expertise of Novella Medical, a Quintiles company.Next to survivalship experience it provides an emotional encounter with fellow males and partners on facing the problems. Especially intimacy and incontinence problems become open topics for dialogue in the group and many times in the couples. Prostate cancers is a chronic disease as opposed to lung or pancreas cancer rendering it easier to see it as a task for life. A new life after treatment to be enjoyed with its restrictions and with grace. What do you think the future retains for addressing quality of life needs in prostate malignancy patients? The development of the genomic and molecular areas of specific medical diagnosis and treatment for each individual patient may be the ultimate goal to assure the perfect outcomes.